Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial ribosomal RNA (rRNA) is a fundamental component of the bacterial ribosome, which is essential for protein synthesis. It is composed of 16S, 23S, and 5S rRNA molecules, which provide structural support and catalytic activity for translation. rRNA is a major target for antibiotics, which bind to rRNA and disrupt ribosome function, inhibiting bacterial growth. The unique structure of bacterial rRNA compared to eukaryotic rRNA makes it a selective target for antibacterial agents. rRNA also plays a role in bacterial evolution and phylogeny, as the 16S rRNA sequence is commonly used for bacterial identification and classification.
Inhibition of bacterial protein synthesis by binding to rRNA, thereby disrupting ribosome function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Ribosomal RNA (rRNA).